PANAXIA LABS ISRAEL LTD Inactive Instrument
Panaxia Labs Israel Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
PNAX
IL0011043630
Investment Management & Fund Operators
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 39.42M 10.61M 885M | Sales 2023 | 19.59M 5.27M 440M | Capitalization | 22.44M 6.04M 504M |
|---|---|---|---|---|---|
| Net income 2022 | -43M -11.57M -966M | Net income 2023 | -13M -3.5M -292M | EV / Sales 2022 | 1.63 x |
| Net Debt 2022 | 36.12M 9.72M 811M | Net Debt 2023 | 36.1M 9.71M 811M | EV / Sales 2023 | 2.99 x |
| P/E ratio 2022 |
-0.65
x | P/E ratio 2023 |
-1.69
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 61.48% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Dadi Segal
CEO | Chief Executive Officer | 48 | 01/19/01 |
Assi Rotbart
CHM | Chairman | 49 | 01/19/01 |
| Director of Finance/CFO | 66 | 28/22/28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michal Yageel
BRD | Director/Board Member | 54 | 29/21/29 |
Tal Yaron Eldar
BRD | Director/Board Member | 60 | 21/16/21 |
Michal Sapir
BRD | Director/Board Member | 66 | 17/22/17 |
Panaxia Labs Israel Ltd is an Israel-based company that is principally engaged in cannabis industry. The Company provides pharma-grade smokeless cannabis products that provide better delivery systems for patients and physicians when properly assessing safety and dosage. Panaxia pharmaceutical cannabis products are specifically tailored to meet a broad range of needs. It's product portfolio includes: NAXIVA-PANAXOL Advanced kit for preparation of cannabis oil-standardized extract, NAXIVA-PANAXOL Purified extract for inhalation, PANAXIR Medical Cannabis Orodispersible Tablets, PANAXIR SENSE Orange Creamsicle Medical cannabis sublingual drops, PANAXIR CBD Melatonin Tablets, PANAXIR Medical cannabis extracts in ethanol among others.
| 1st Jan change | Capi. | |
|---|---|---|
| -5.26% | 94.17B | |
| +19.64% | 27.7B | |
| -1.00% | 18.41B | |
| +4.45% | 15.29B | |
| +15.26% | 15.55B | |
| -20.31% | 12.49B | |
| +24.50% | 9.29B | |
| +13.56% | 9.3B | |
| +26.56% | 7.11B |
